不同剂量小檗碱对大鼠缺血心肌的保护作用
摘要
目的验证小檗碱是否对大鼠梗死后心脏具有保护作用,并初步探讨小檗碱的这种保护作用是否随剂量的改变而有统计学差异。
方法将56只大鼠随机分为7组,每组各8只大鼠。即：假手术组,模型组,小檗碱100mg/kg,小檗碱150mg/kg,小檗碱200mg/kg,小檗碱250mg/kg和普奈洛尔组。各组大鼠均按照自己组规定药品剂量进行灌胃,总共灌胃7天,每天灌胃1次。每组大鼠均于第2天灌胃4小时后,采用开胸结扎冠脉方法制作心肌梗死模型。模型建立成功后,各组大鼠继续灌胃5天。每组大鼠均于第7次灌胃后4小时测量相关心功能参数,之后收集心脏和血液标本作相关项目分析。
结果小檗碱可以显著改善大鼠梗死后的心脏功能,显著减小大鼠梗死后心脏的缺血范围和梗死范围并显著降低大鼠血清中心肌乳酸脱氢酶(LDH, lactate dehydrogenase)的含量。且在实验条件下,不同剂量小檗碱对大鼠梗死后心脏的保护作用有统计学差异。
结论小檗碱对大鼠梗死后心脏有显著的保护作用,且小檗碱的这种保护作用随剂量的不同有统计学差异。
Objective:To testify berberine (Ber) has or not the protective effect on the infacted heart on the rat. And to explor initially the protective effect of berberine with the different doses have the different results.
Methods:56Wistar rats were randomly divided into7groups, there were8rats in each group. There are the sham operation group, the model group, the berberine with100mg/kg group, the berberine with150mg/kg group, the berberine with200mg/kg group, the berberine with250mg/kg group and the Propranolol group. The rats were given drugs by the gavage method with different medicines and different dosees. All rats would be gavaged7days. And the frequency was one time a day. Using the thoracotomy and the coronary artery ligation to establish the myocardial infarction models on the second day after the first gavage. All rats were killed after measuring the relevant parameters of the heart functions. And the hearts and blood samples were collected for the analysis.
Result:Berberine could improve obviously the function of the rats, and reduce the infarct and the ischemia sizes in the hearts of the rats. And it also decrease the level of LDH in the blood of the rats. And under the experimental conditions, the results of the groups of berberine different doses had significant difference.
Conclusion:Berberine can significantly improve the function of the infarction heart in rats, and the function of berberine with different doses have significant difference.
方法将56只大鼠随机分为7组,每组各8只大鼠。即：假手术组,模型组,小檗碱100mg/kg,小檗碱150mg/kg,小檗碱200mg/kg,小檗碱250mg/kg和普奈洛尔组。各组大鼠均按照自己组规定药品剂量进行灌胃,总共灌胃7天,每天灌胃1次。每组大鼠均于第2天灌胃4小时后,采用开胸结扎冠脉方法制作心肌梗死模型。模型建立成功后,各组大鼠继续灌胃5天。每组大鼠均于第7次灌胃后4小时测量相关心功能参数,之后收集心脏和血液标本作相关项目分析。
结果小檗碱可以显著改善大鼠梗死后的心脏功能,显著减小大鼠梗死后心脏的缺血范围和梗死范围并显著降低大鼠血清中心肌乳酸脱氢酶(LDH, lactate dehydrogenase)的含量。且在实验条件下,不同剂量小檗碱对大鼠梗死后心脏的保护作用有统计学差异。
结论小檗碱对大鼠梗死后心脏有显著的保护作用,且小檗碱的这种保护作用随剂量的不同有统计学差异。
Objective:To testify berberine (Ber) has or not the protective effect on the infacted heart on the rat. And to explor initially the protective effect of berberine with the different doses have the different results.
Methods:56Wistar rats were randomly divided into7groups, there were8rats in each group. There are the sham operation group, the model group, the berberine with100mg/kg group, the berberine with150mg/kg group, the berberine with200mg/kg group, the berberine with250mg/kg group and the Propranolol group. The rats were given drugs by the gavage method with different medicines and different dosees. All rats would be gavaged7days. And the frequency was one time a day. Using the thoracotomy and the coronary artery ligation to establish the myocardial infarction models on the second day after the first gavage. All rats were killed after measuring the relevant parameters of the heart functions. And the hearts and blood samples were collected for the analysis.
Result:Berberine could improve obviously the function of the rats, and reduce the infarct and the ischemia sizes in the hearts of the rats. And it also decrease the level of LDH in the blood of the rats. And under the experimental conditions, the results of the groups of berberine different doses had significant difference.
Conclusion:Berberine can significantly improve the function of the infarction heart in rats, and the function of berberine with different doses have significant difference.
引文
[1]Diehm C, Schuster A, Allenberq JR, etal. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients:cross-sectional study[J]. Atherosclerosis,2004, 172(1):95-105.
[2]Scarabelli TM, Knight R, Stephanou A, etal. Clinical implications of apoptosis in ischemic myocardium[J].Curr Probl Cardiol,2006,31(3):181-264.
[3]Wang TD, Chen WJ, Su SS, etal. Increased cardiomyocyte apoptosis following ischemia and reperfusion in diet-induced hypercholes-terolemia:relation to Bcl-2 and Bax proteins and capase-3 activity[J].Lipids,2002,37(4):385-394.
[4]Shirito K, Otani H, Yamamoto F, etal. MK2-gene knockout mouse hearts carry anti-apoptotic signal and are resistant to ischemia reperfusion injury[J].J Mol Cell Cardiaol,2005538(1):93-97.
[5]刘胜中,杨双强.心肌缺血—再灌注损伤机制研究进展[J].实用医院临床杂志,2007,4(1)：88-90.
[6]Scarabelli TM, Knight R, Stephanou A, etal. Clinical implications of apoptosis in ischernic myocardium[J].Curr Probl Cardiol,2006,31(3):181-264.
[7]祖玉,徐建国,蓝庭剑.黄连素对灌流心脏发生心衰的保护作用[J].华西医科大学学报.2001,32(3)：417-418.
[8]张晓丹,任宏敏,刘琳等.小檗碱抗心力衰竭作用研究概况[J].中国药业,2007,16(24)：19-20.
[9]张爱先.中医药治疗快速心律失常的研究概况[J].中国中西医结合急杂志,2002,9(1)：56-57.
[10]储钟禄,黄才国,徐志平.小檗碱的抗血小板作用和机制[J].中国中西医结合杂志,1994,14(8)：510-512.
[11]Brandes RP,Schmitz-Winnenthal FH, Feletou M, etal. An endotheliumderived hyperpolarizing factor distinct from NO and prostacyclin is a major endothclium. dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice[J]. Proc Natl Acad Sci USA,2000,97(17):74-75.
[12]付明耀.小檗碱的药理作用及临床应用[J].中华医学杂志,2004,4(3)：87-89.
[13]凌云,周祖玉,陶大昌等.黄连素对缺血再灌注心肌细胞损伤的保护作用[J].四川大学学报(医学版),2003,34(3)：452-454.
[14]周祖玉,徐建国,蓝庭剑.黄连素对灌流心脏发生心衰的保护作用[J].华西医科大学学报,2001,32(3)：417-418.
[15]房辉,汪晖,李泱.小檗碱对急性缺血心肌的保护作用[J].咸宁学院学报(医学版),2004,18(5)：308-310.
[16]Li B, Zhu WL, Chen KX. Advances in the study of berberine and its derivatives[J].Acta Pharma Sinica,2008,43(8):773-787.
[17]Pan GY, Wang GJ, Liu XD, etal. The involvement of glycoprotein in berberine absorption[J]. Pharmacol Toxicol,2002,91(4):193-197.
[18]Huang C, Zhang YB, Gong Zw etal. Berberine inhibits 3T3-L1 adipocyte diferentiation through the PPAR Y pathway [J].Biochem Biophys Res Commun,2006,348(2):571-578.
[19]温柏林.黄连素治疗心律失常临床观察[J].中华心血管病杂志,1988,16(5)：277.
[20]赵学忠.小檗碱抗心律失常的临床观察与心脏电生理研究[J].中华心血管杂志,1989,17(3)：159.
[21]顾连和.口服黄连素治疗房宣早搏30倒疗效初步观察[J].临床荟莘,1991,6(2)：71.
[22]何友作.黄连素治疗心脏旱搏及房颤的临床观察[J].临床医学,1991,11(1)：27.
[23]万青.盐酸小檗碱治疗过早搏动89例临床观察[J].铁道师院学报,1996,13(4)：61-63.
[24]韩芳化,黄筑荣.盐酸小檗碱治疗室早2000例[J].中国现代医学杂志,2001,11(5)：104-106.
[25]孟杰,宋桂芳.盐酸小檗碱治疗心律失常30例临床观察[J].吉林医学信息,1999,14(8)：13-15.
[26]孙海英,刘树文.谷维素和盐酸小檗碱合用治疗室性心律失常91例[J].陕西医学杂志,2007,36(7)：925-926.
[27]李辉.盐酸小檗碱在心血管疾病中的应用[J].临床军医杂志,2005,33(4)：815-816.
[28]杜见益.黄连素治疗心律失常108例的疗效观察[J].海南医学,2006：17(7)：86-71.
[29]Wang YX, Zheng YM, Zhou XB. Inhibitory effects of berberine on ATP. sensitive K+ channels in cardiac myocytes[J].Eur J Pharmacol,1996,316(3):307-315.
[30]黄伟民等.黄连素治疗心律失常的基础电生理学研究[J].心电学杂志,1985,12(4)：2.
[31]黄伟民等.黄连素延长腺鼠心室乳头肌动作电位时程的机理研究[J].心电学杂志,1987,21(6)：49.
[32]方诂超等.小檗碱的抗心室纤颤作用[J].中国药理学报,1986,7(4)：321.
[33]孙晓东,李金鸣,田丽君等.小檗碱对豚鼠心室乳头状肌慢内向离子电流的作用[J].中国药理学报,1989,10(2)：130-134.
[34]黄伟民等.黄连素对小鼠心肌内总钙维度的影响[J].中国药学杂志,1990,25(1)：3.
[35]司晓晨.盐酸小檗碱片对钙离子通道的拮抗作用[J].南京中医药大学学报,1996,12(6)：20-22.
[36]王建文,张文军.盐酸小檗碱的几种新用途[J].中国医学杂志,2004,2(8)：507-508.
[37]Wang YX, Yao XY, Tan YH. Effects of berberine on delayed after depolarizations in ventricular muscles in vitro and in vivo[J].J Cardiovasc Pharmacol,1994,23(36):7216-7221.
[38]Huang WM, Yan H, Lin JM, et al. Beneficial effects of berberine on hemodynamics during acute ischemic left ventricular failure in dogs[J].Chin Med J,1992,105(12):1014-1019.
[39]杨立新.黄连素治疗高血压病53例疗效观察[J].临床荟萃,1990,5(10)：454.
[40]林斌,陈维圣.黄连素一个月疗法治疗高血压伴室性早搏的临床观察[J].福建医药杂志,1996,18(1)：98-99.
[41]郝文.黄连素在内科疾病中的应用[J].实用中医内科杂志,1997,11(2)：20.
[42]钟树林,周永生,陈海明等.黄连素治疗老年高血压病96例临床观察[J].中国老年学杂志,1997,17(6)：349-350.
[43]韩振祥,黄金秀,张志深等.倍他乐克加黄连素治疗老年高血压病观察[J].医学研究通讯,1999,28(4)：43.
[44]张学芳,徐祗云,李玉平.黄连素的临床新用途[J].职业与健康,2000,16(6)：94-95.
[45]王辉武.中药临床新用[M].北京：人民卫生出版社,2001.547.
[46]魏银福,刘宏义.黄连素治疗高血压病38例疗效观察[J].内蒙古医学杂志,2000,32(3)： 192-193.
[47]张思坦,潘俊亭.黄连素治疗高血压病82例临床观察[J].包头医学院学报,1996,12(1)：46-47.
[48]王文雅,陈克敏,关永源等.盐酸小檗碱对毒草碱型受体的作用[J].药学学报,1999,34(4)：260-263.
[49]Kang DG, Sohn EJ, Kwon EK, etal. Effects of berberine on angiotensin-converting enzyme and NO/cGMP system in vessels[J].Vasc Pharmacol,2002,39(6):281-286.
[50]Ko WH, Yao XQ, Lau CW, etal. Vasorelaxant and anti-proliferative effect of berberine[J].Eur J Pharmacol,2000,399(2):187-196.
[51]Chi CW, Chang YF, Chao TW, etal. Flowcometric analysis of the effect of berberine on the expression of glucocorticoid receptors in human hepatoma HepG2 ceils[J].Life Sci,1994,54(64):2099-2107.
[52]何国厚,刘勇,艾志兵等.小檗碱对兔颈动脉粥样硬化形成的干预作用[J].神经损伤与功能重建,2006,1(1)：42-44.
[53]左彦方,郭毅,姜昕等.小檗碱对兔动脉粥样硬化及其血脂的影响[J].中国脑血管病杂志,2006,3(5)：204-207.
[54]何国厚,艾志兵,刘勇等.小檗碱对兔颈动脉粥样硬化中内膜增生和吞噬细胞趋化作用的影响[J].中风与神经疾病杂志,2006,23(1)：94-96.
[55]周岚,何国厚,李承晏等.小檗碱对颈动脉粥样硬化家兔血管紧张素的影响[J].卒中与神经疾病,2006,13(4)：212-214.
[56]Eden ER, Patel DD, Sun XM, etal. Restoration of LDL Receptor function in cells from patients with autosom al recessive hypercholesterolemia by retroviral expression of ARH1[J].J Cin Invest,2002,110(11):1695-1702.
[57]Lee S, Lim HJ, Park JH, et al. Berberine-induced LDLR up-regulation involves JNK pathway[J].Biochem Biophys Res Commun,2007,362(4):853-857.
[58]Clabaut A, Deplace S, Chauveau C, etal. Human osteob lasts derived from m esenchym stem cells express adipogenic marker upon coculture with bone marrow adipocyte[J]. Differen tiation,2010,80(1):40-45.
[59]Xing LJ, Zhang L, Lin T, et al. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease(NAFLD) rat liver[J].Eur J Pharmacol, 2011,668(3):467-471.
[60]陈其明,谢明智.黄连及小檗碱降血糖作用的研究[J].药学学报,1986,21(6)：401-4031.
[61]李萍.小檗碱对心血管系统的药理作用[J].中国药学通报,2001,7(5)：324.
[62]Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus[J]. Metabolism,2008,57(13):712.
[63]陈其明,谢明智.黄连及小檗碱降血糖作用的研究[J].药学报,1986,21(16)：401-406.
[64]宋菊敏,毛良,施建玲等.黄连素对非胰岛素依赖型糖尿病大鼠的抗氧化作用[J].中草药,1992,23(11)：590-591.
[65]金丹.黄连解毒汤及黄连素对2型糖尿病大鼠靶组织中磷脂酰肌醇-3激酶mRNA和蛋白表达的影响[D].华中科技大学硕士学位论文,2006：9.
[66]闫秀敏,黎明,邢雪林.浅谈黄连素的药理与临床应用[J].中国医药卫生,2005,6(3)：62.
[67]唐玲光.黄连素巧治糖尿病[J].医药与保健,2005,13(6)：40.
[68]李素迎,姚运纬,伍忍.盐酸小檗碱对链脲霉素致大鼠离体胰岛B细胞损伤的影响[J].中国现代医学杂志,2002,12(18)：6-8.
[69]Yu C, Zhang H, Pan JF, etal. Determination and preliminary studies of metabolism of berberine in human urine after oral administration[J].Chin J Clin Pharmacol(中国临床药理学杂志),2000,16(1)：36-39.
[70]Pan JF, Yu C, Zhu DY, etal.Identification of three sulfate conjugated metabolites of berberine chloride in healthy volunteer's urine after oral administration[J]. Acta Pharmacol Sin(中国药理学报),2002,23(1)：77-82.
[71]宋菊敏,毛良,李有良.黄连对2型糖尿病的抗氧化作用[J].中草药,1992,23(11)：540.
[72]吕霞,王晶,蒋文强等.黄连的研究进展.山东医药工业[J],2003,22(6)：33-35.
[73]Liu WH, Hei ZQ, Nie H, et al. Berberine ameliorates renal injury in streptozotocin -induced diabetic rats by suppression of both oxidative stress and aldose reductase[J].Chin Med J(Engl), 2008,121(36):706.
[74]Zhou LB, Wang X, Shao L, et al. Berberine Acutely Inhibits Insulin Secretion fromβ-Cells through 3,5-Cyclic Adenosine 5-Monophosphate Signaling Pathway[J]. Endocrinology,2008, 149(9):4510.
[75]Tang LQ, Wei W, Chen LM, et al. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats[J].J Ethnopharmacol,2006,108:109.
[76]李应霞,成小蔓,何海霞.黄连小檗碱对大鼠糖尿病模型中血糖的影响[J].医学研究杂志,2007,26(11)：70.
[77]Fu D, O Neill RA. Monosaccharide composition analysis of oligosaccharides and glycoproteins by high 2 performance liquid chromatography[J].Anal Biochem,1995,227(2):337-384.
[78]Xiong MQ, Zhu ZZ.The study of diabetis treatment and insulin resistance improvement by Chinese medicine[J].Chin Tradit Med New Drugs Clin Pharmacol (中药新药与临床药理), 1994,5(4):47-50.
[79]Gao CR, Zhang JQ, Hung QL. Experimental study on berberin raised insuliu sensitivity in insul inresistance rat models[J].Chin J Integrated Tradit West Med (中国中西医结合杂志), 1997,17(3):162-164.
[80]Lu SS, Yu YL, Zhu Haojie, etal. Berberine promotes glucagon-like peptide-1(7-36) amide secretion in streptozotocin-induced diabetic rats [J]. Society for Endocrinology,2008,1 (2):120-122.
[81]Cheng Z, Pang T, Gu M, etal. Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK[J].Biochim Biophys Acta,2006,14(13):678-682.
[82]Woo Sik Kim, Yun Sok Lee, Seung Hun Cha, etal. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. Am J Physiol Endocrinol Metab[J].2009,36(24):812.
[83]Kong WJ, Zhang H, Song DQ, etal. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression[J].Metabolism,2009,9(58): 109.
[84]LIN CC, LIN SY, CHUNG JG, etal. Down-regulation of cyclin B1 and up-regulation of Weel by berberine promotes entry of leukemia cells in to the G2/M-phase of the cell cycle[J].Anticancer Res,2006,10(26):1097-1104.
[85]魏敬,吴锦丹,蒋建东等.盐酸小檗碱治疗2型糖尿病合并脂肪肝的临床研究[J].中西医结合肝病杂志,2004,14(6)：334.
[86]Zhang Y, Li X, Zou D,etal. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine[J].J Clin Endocrinol Metab,2008,93(7):2559.
[87]Yin J, Xing H, Ye J. Efficacy of berberine in patient s with type 2 diabetes mellitus[J]. Metabolism,2008,57(5):712.
[88]Zhou JY, Zhou SW, Zhang KB, et al.Chronic effects of berberine on blood,liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats[J]. Biol Pharm Bull, 2008,31(6):1169.
[89]欧阳礼枝,陆付耳,刘文军等小檗碱对胰岛素抵抗大鼠肝脏葡萄糖激酶及其调节蛋白的影响[J].世界华人消化杂志,2007,15(8)：885.
[90]王增四,陆付耳,陈广等.小檗碱对NIT-1细胞胰岛素分泌和葡萄糖激酶活性的影响[J].药学学报,2007,42(10)：1045.
[91]Kong W, Wei J, Abidi P, etal. Berberine is a novel cholesterol lowering drug working through a unique mechanism distinct from statins[J]. Nat Med,2004,10(12):1344.
[92]Brusq JM, Ance llin N, Grondin P, etal.Inhibition of lipid synthesis through activation of AMP kinase an additional mechanism for the hypolipidemic effects of berberine[J].J Lipid Res,2006,47(6):1281-1288.
[93]Kong W, Wei J, Abidi P, etal. Berberine is a novel cholesterol21owering drug working through a unique mechanism distinct fromstatins[J]. Nat Med,2004,10(12):1344.
[94]Huang C, Zhang Y, Gong Z, etal.Berberine inhibits 3T32L1 adipocyte differentiation through the PPAR gamma pathway[J].Biochem Biophys Res Commun,2006,348(2):571.
[95]Cemakova M, Kostalova D. Antimicrobial activity of berberine-a constituent Of Mahonia aquifolium[J].Folia Mierobiol,2002,47(4):375-378.
[96]马连珍,王爱玲,刘和善.黄连的临床应用[J].中国民间疗法,2003,11(8)：44-45.
[97]周祖玉,徐建国,蓝庭剑.黄连素对灌流心脏发生心衰的保护作用[J].华西医科大学学报,2001,32(3)：417-418.
[98]智光,黄大显,杨兴生.黄连素治疗心功能衰竭的实验和临床观察[J].中华内科杂志,1991,30(9)：581-582.
[99]康巧真,叶菲,杨顺裕.黄连素治疗充血性心力衰竭17例疗效观察[J].中国自然医学杂志,2002,4(2)：83-84.
[100]董德利,孙建平,罗大力等.小檗碱对豚鼠心室肌细胞胞浆内游离钙离子浓度的影[J].中国药理学与毒理学杂志,2000,14(2)：128-130.
[101]Hui KK, Yu JL, Chan WF. etal. Interaction of berberine with human platelet alpha 2 adrenoceptors[J].Life Scicene,1991,49(18):315-324.
[102]汪永孝,姚秀娟,谭月华.小檗碱对豚鼠离体心肌生理特性的影响[J].中国药理学报,1987,8(3)：220-223.
[103]唐青云,李国海,李久玲等.静滴盐酸黄连素对心血管机能的影响[J].医药工业,1985,16(3)：130-132.
[104]李新天,王幼林.小檗碱对培养大鼠心肌细胞胞内游离Ca的作用[J].药学学报,1997,32(10)：721-725.
[105]宋云可,刘红旗,李世东.小檗碱对心血管系统的作用及临床应用[J].山东医药工业,1997,16(5)：28-29.
[106]关中宪.黄连素治疗心力衰竭28例[J].临床荟萃,1993,8(17)：859.
[107]Hong Y, Hui SS, Chan BT, etal. Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy[J].Life Sci,2003,72(22):2499-2507.
[108]HONG Y, HUI S C, CHAN T Y, etal. Effect of berberine on regression of pressure overload induced cardiac hypertrophy in rats[J].Am J of Chinese M, Micine,2002,30(4):588-599.
[109]洪缨,解欣然,谢俊大等.小檗碱对压力超负荷致心肌肥厚模型大鼠心脏结构的影响[J].北京中医药大学学报,2006,29(7)：465-467.
[110]洪缨,王晶,赵海苹等小檗碱对2肾1夹致心肌肥厚大鼠心室重构的影响[J].北京中医药大学学报,2005,28(6)：28-31.
[111]Ji ES, Yue H, Wu YM, etal. Effects of phytoestrogen genistein on myocardial ischemia /reperfusion injury and apoptosis in rabbits[J].Acta Pharmacol sin,2004,25(3):306-312.
[112]熊利华,苏艳玲,华平等.不停跳心内直视手术的临床研究[J].中山大学学报(医学科学版),2004,25(1)：221-223.
[113]HON6 Y, HM ISC, CHA NTY, etal.Effect of berberine on regres sion0f Press LI recover 10 adind Ucedcardiac hypertrophy in rats. Am J of Chinese[J], Micine,2002,30(4):588-599.
[114]Hong Y, Hui SS, Chan B T, etal. Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy[J]. Life Scicene,2003,72(22):2499-2507.
[115]Huang M, Yan H, Lin JM, etal. Beneficial effects of berberine on hemodynamics during acute ischemic left ventricular failure in dogs[J].Chin Med J,1992,105(12):1014-1019.
[116]Wang CM, Li J, Lv X etal. Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin[J].Eur J Pharmacol,2009,620(1):131-137.
[117]Wang YQ, Huang Lam KS, etal. Berberine prevents hypergly-cemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase[J].Cardiovasc Res,2009,82(3):484-492.
[118]Kang DG, Sohn EJ, Kwon EK, etal. Effects of berberine on angiotensin-converting enzyme and NO/cGM P system in vessels[J].Vase Pharrnacol,2002,39(6):281-286.
[119]Correch6 ER, Andujar SA, Kurdelas RR, etal. Antioxidant and cytotoxic activities of canadine:biological effects and structural aspects[J].Bioorg Med Chem,2008,16(7):3641-3651.
[120]Thimpurasundari CJ, Pedmini R, Devaraj SN. Effect of berberine Oil the antioxidant, uhmstruetural modifications and protein bound carbohydrates in azoxymethane-induced Colon cancer in rats[J].Chem Biol Interact,2009,177(3):190-195.
[121]Choi DS, Kim SJ, Jung MY. Inhibitory activity of berbefine on DNA strand cleavage induced by hydrogen peroxide and cytochromec[J].Biosei-Biotechnol-Bioehem,2001,65(2):452-455.
[122]刘星.蜂王浆对实验性2型糖尿病大鼠心肌的保护作用[J].牡丹江医学院报,2003,24(5)：1-3.
[123]Shirwaikar A, Shirwaikar A, Pmjendmn K, etal.In vitro antiox-idant studies on the benzyl tetra isoquinoline alkaloid berbefine[J].Biol Pharm Bull,2006,29(9):1906-1910.
[124]Weaver ME. A quantitative study of the anatomy and distribution of coronary arteries in comparison with other animals and man[J].Cardiovasc Res,1986,20(12):907.
[125]刘国辉,刘志跃.实验性心肌梗死动物模型复制方法研究进展[J].实验动物科学与管理,2005,22(4)：362.
[126]Berg RA, Sanders AB, Kern KB, etal. Adverse hemodynamic effects of interrupting chest compressions for rescue breat hing during cardiopulmonary resuscitation for ventricular cardie arrest[J].Circulation,2001,104(20):2465.
[127]Odenstedt J, Mansson C, Jansson SO, etal. Endocardial electromechanical mapping in a porcine acute infarct and reperfusion model evaluating the extent of myocardial ischemia[J].J Invasive Cardiol,2003,15(9):497.
[128]Zhao ZQ, Vinten-Johansen J. Postconditioning:Reduction of reperfusion-induced injury[J]. Cardiovasc Res,2006,70(2):200-211.
[129]Crisostomo PR, Wairiuko GM, Wang M, etal. Preconditioning versus postconditioning: mechanisms and therapeutic potentials[J].Am Coll Surg,2006,202(5):797-812.
[130]Skyschally A, Schulz R, Heusch G. Pathophysiology of myocardial infarction:protection by ischemic pre- and postconditioning[J].Herz,2008,33(2):88-100.
[131]卢新政,王连生,黄峻等.冠状动脉堵闭法建立猪心肌梗死模型[J].中国动脉硬化杂志,2004,12(2)：218.
[132]徐淑云.药理实验方法学(第3版)[M].北京：人民卫生出版社,2002：921.
[133]Reek S, Bicknell JL, Walcott GP, etal. Induciblity of sustained ventricular tachycardia in a closed-chest ovine model of myocardial infarction[J].Pacing Clin Electrophysiol,1999,22(4): 605-614.
[134]Sasaki H, Shimizu M, Ogawa K, etal. Brief ischemia-reperfusion performed after prolonged ischemia (ischemic postconditioning) can terminate reperfusion arrhythmias with no reduction of cardiac function in rats[J].Int Heart J,2007,48(2):205-213.
[135]Vinten-Johansen J. Postconditioning:a mechanical maneuver that triggers biological and molecular cardioprotective responses to reperfusion[J].Heart Fail Rev,2007,12(3):235--244.
[136]Hausenloy DJ, Yellon DM. Survival kinases in ischemic preconditioning and postconditioning[J]. Cardiovasc Res,2006,70(2):240-253.
[137]金惠铭,王建枝.病理生理学(第6版)[M].北京：人民卫生出版社,2006：214.
[138]金惠铭,王建枝.病理生理学(第7版)[M].北京：人民卫生出版社,2006：207.
[139]Huang Z, Wang L, Meng S, etal. Berberine reduces both MMP-9 and EMMPRN expression through prevention of P38 pathway activation in PMA-induced macrophages[J].Int J Cardiol,2009,36(12):224-225.
[140]Kim S, Choi JH, Kim JB, etal. Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer celIs[J].Molecules,2008,13(15):2978-2985.
[141]Lin JF, Yang JS, Wu CC, etal. Berberine induced down-regulation of matrix metalloproteinase-1,-2 and -9 in human gastric cancer cells(SNU-5) in vitro[J].In Vivo,2008, 22(18):223-230.
[1]潘清平,黄连[M].北京：中国中医药出版社,2001,3-4.
[2]江苏新医学院编.中药大辞典[M].上海：上海科学技术出版社,1996：2024-2025.
[3]杨勇,叶小利,李学刚.4种黄连生物碱的抑菌作用[J].时珍国医国药,2007,12,18(12)：3013-3014.
[4]Yang Y, Ye X L, Li X G, et al. Synthesis and antimicrobial activity of 8-alkyl berberine derivatives with a long aliphatic chain[J].Planta Med,2007,73:602-604.
[5]孟甄,金建玲,刘玉庆等.细菌耐药性的诱导与消除[J].中国药理学通报,2003,19(9)：1047-1051.
[6]Tae S, Kim H, Bok Y, etal. Induction of interleuk in 212 production in mouse marcophage by berberine, a benzodioxo loquino lizine alkaloid, deviates CD4+ T cells from a Th2 to a Thl respones[J].Immunology,2003,109:407-414.
[7]HUANG CG,CHU ZL. Effect of berberine on arachidonic acid metabolism in rabbit plate lets and endothelial cells[J].Thromb Res,2002,106(4-5):223-227.
[8]Russel Ross. A therosclerosis an inflammation disease[J].The New England Journal of Medicine,1999,340(2):115-126.
[9]方放治,戴得哉,王自正等.氯苄四氢小檗碱对抗H202引起无血清培养的血管内皮细胞凋亡及坏死[J].中国临床药理学杂志,2002,7(3)：200-204.
[10]Kang DG, Sohn EJ, Kwon EK, et al. Effect of berberine on abgio tensin2converting enzyme and NOocGM P system in vessels[J].Pharmaco,2002,39 (1):281.
[11]Huang CG, Chu Zhong L, Wei Shang J. Effect of berberine on arachidonic acid metabolism in rabbit platelets and endothelial cell[J].Thrombosis Rearch,2002,106:223-227.
[12]席刚明,何国厚,黄朝芬等.小檗碱对脑梗死患者血浆ICM21和E2-Selectin的影响[J].中风与神经疾病杂志,2003,20(6)：273.
[13]Ko WH, Wao XQ. Vaso relaxant and anti-proliferative effect of berberine [J]. European Journal of Pharmaco logy,2000,39 (9):187-196.
[14]Cui HS, Matsumoto K, Murakami Y, etal. Berberine exerts neuroprotective actions against in vitro ischemia-induced neuronal cell damage in organotypic hippocampal slice cultures:involvement of B-cell lymphoma 2 phosphorylation suppression[J].Biol Pharm Bull,2009,32(1):79-85.
[15]陈施艳,林红,吴秀丽等.小檗碱对大鼠脑缺血后MCP-1表达的影响[J].卒中与神经疾病,2008,15(4)：323-326.
[16]Wang F, Zhao G, Cheng L, etal. Effects of berberine on potassium currents in acutely isolated CA1 pyramidal neurons of rat hippocampus. Brain Res[J].2004,999(1):91-97.
[17]于秀辰,李靖,王世东.黄连素在糖尿病中的治疗作用.中国基础医学杂志,2002,8(10)：46-48.
[18]于秀辰,李靖,赵进喜.黄连素治疗2型糖尿病30例临床观察.中国临床医生,2003,31(5)：48.
[19]刘长山,王秀军,柳林等.黄连素对醛糖还原酶活性的抑制及其防治糖尿病神经病变的临 床意义.中国中药杂志,2002,27(12)：950-952.
[20]高从容,张家庆,黄庆玲.黄连素增加胰岛素抵抗大鼠模型胰岛素敏感性的实验研究.中国中西医杂志,1997,17(3)：162-164.
[21]陈莉,张玉.黄连素合六味地黄丸治疗2型糖尿病123例[J].国医论坛,2002,17(2)：37.
[22]姚冬春,王雪莲,扬志.黄连素的临床新用途[J].牡丹江医学院学报,2001,22(1)：70.
[23]徐蓉,徐孝麟.黄连素在非感染疾病中的临床应用[J].实用医院临床杂志,2005,2(4)：87.
[24]HUANG CG,CHU ZL. Effect of berberine on arachidonic acid metabolism in rabbit plate lets and endothelial cells[J].Thromb Res,2002,106(4-5):223-227.
[25]HAO Y, QIU QY, Wang WJ, etal. Effects of berberine on lymphocyte-endothelium adhesion and adhesion molecule expression[J].Chin J Immuno,1999,15(11):523-525.
[26]Jing Wang, Yanjun Zhang, Shuai Du, etal. Protective effects of berberine against amyloid beta-induced toxicity in cultured rat corticalneurons[J].Neural Regeneration Research,2011,6(3):183-187.
[27]李彩莲,王芳,刘超等小檗碱对Aβ25-35诱导大鼠PC12细胞损伤的保护作用[J].中国科技论文在线,2006,1(1)：269-274.
[28]Guang Y, Li Y, Tian Q, etal. Berberine Attenuates Calyculin AInduced Cytotoxicity and Tau Hyperphosphorylation in HEK293 Cells[J].J Alzheimers Dis,2011, 24(2):1-2.
[29]Asai M, Iwata N, Yoshikawa A, etal. Maruyama K. Berberine alters the processing of Alzheimers amyloid precursor protein to decrease Abeta secretion [J].Biochem Biophys Res Commun,2007,352(2):498-502.
[30]Domitrovi R, Jakovac H, Blagojevi G. Hepatoprotective activity of berberine is mediated by inhibition of TNF-a, COX-2, and i-NOS expression in CCl(4)-intoxicated mice[J]. Toxicology, 2011,280(1-2):33-43.
[31]Cui HS, Matsumoto K, Murakami Y, etal. Berberine exerts neuroprotective actions against in vitro ischemia-induced neuronal cell damage in organotypic hippocampal slice cultures:involvement of B-cell lymphoma 2 phosphorylation suppression[J].Biol Pharm Bull,2009,32(1):79-85.
[32]Sabir M. Indian J Med Res,1977(65):305.
[33]孙强,朱冰芝,陈亚娟.黄连灌肠治疗慢性溃疡性结肠炎173例[J].现代中西医结合杂志,2003,12(10)：1024.
[34]Subbaramaiah K, Dannenkerg AJ.Cyclooxygenase2:a molecular target for cancer prevention and treatment[J].Trends in pharmacological sciences,2003,24(2):96.
[2]Scarabelli TM, Knight R, Stephanou A, etal. Clinical implications of apoptosis in ischemic myocardium[J].Curr Probl Cardiol,2006,31(3):181-264.
[3]Wang TD, Chen WJ, Su SS, etal. Increased cardiomyocyte apoptosis following ischemia and reperfusion in diet-induced hypercholes-terolemia:relation to Bcl-2 and Bax proteins and capase-3 activity[J].Lipids,2002,37(4):385-394.
[4]Shirito K, Otani H, Yamamoto F, etal. MK2-gene knockout mouse hearts carry anti-apoptotic signal and are resistant to ischemia reperfusion injury[J].J Mol Cell Cardiaol,2005538(1):93-97.
[5]刘胜中,杨双强.心肌缺血—再灌注损伤机制研究进展[J].实用医院临床杂志,2007,4(1)：88-90.
[6]Scarabelli TM, Knight R, Stephanou A, etal. Clinical implications of apoptosis in ischernic myocardium[J].Curr Probl Cardiol,2006,31(3):181-264.
[7]祖玉,徐建国,蓝庭剑.黄连素对灌流心脏发生心衰的保护作用[J].华西医科大学学报.2001,32(3)：417-418.
[8]张晓丹,任宏敏,刘琳等.小檗碱抗心力衰竭作用研究概况[J].中国药业,2007,16(24)：19-20.
[9]张爱先.中医药治疗快速心律失常的研究概况[J].中国中西医结合急杂志,2002,9(1)：56-57.
[10]储钟禄,黄才国,徐志平.小檗碱的抗血小板作用和机制[J].中国中西医结合杂志,1994,14(8)：510-512.
[11]Brandes RP,Schmitz-Winnenthal FH, Feletou M, etal. An endotheliumderived hyperpolarizing factor distinct from NO and prostacyclin is a major endothclium. dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice[J]. Proc Natl Acad Sci USA,2000,97(17):74-75.
[12]付明耀.小檗碱的药理作用及临床应用[J].中华医学杂志,2004,4(3)：87-89.
[13]凌云,周祖玉,陶大昌等.黄连素对缺血再灌注心肌细胞损伤的保护作用[J].四川大学学报(医学版),2003,34(3)：452-454.
[14]周祖玉,徐建国,蓝庭剑.黄连素对灌流心脏发生心衰的保护作用[J].华西医科大学学报,2001,32(3)：417-418.
[15]房辉,汪晖,李泱.小檗碱对急性缺血心肌的保护作用[J].咸宁学院学报(医学版),2004,18(5)：308-310.
[16]Li B, Zhu WL, Chen KX. Advances in the study of berberine and its derivatives[J].Acta Pharma Sinica,2008,43(8):773-787.
[17]Pan GY, Wang GJ, Liu XD, etal. The involvement of glycoprotein in berberine absorption[J]. Pharmacol Toxicol,2002,91(4):193-197.
[18]Huang C, Zhang YB, Gong Zw etal. Berberine inhibits 3T3-L1 adipocyte diferentiation through the PPAR Y pathway [J].Biochem Biophys Res Commun,2006,348(2):571-578.
[19]温柏林.黄连素治疗心律失常临床观察[J].中华心血管病杂志,1988,16(5)：277.
[20]赵学忠.小檗碱抗心律失常的临床观察与心脏电生理研究[J].中华心血管杂志,1989,17(3)：159.
[21]顾连和.口服黄连素治疗房宣早搏30倒疗效初步观察[J].临床荟莘,1991,6(2)：71.
[22]何友作.黄连素治疗心脏旱搏及房颤的临床观察[J].临床医学,1991,11(1)：27.
[23]万青.盐酸小檗碱治疗过早搏动89例临床观察[J].铁道师院学报,1996,13(4)：61-63.
[24]韩芳化,黄筑荣.盐酸小檗碱治疗室早2000例[J].中国现代医学杂志,2001,11(5)：104-106.
[25]孟杰,宋桂芳.盐酸小檗碱治疗心律失常30例临床观察[J].吉林医学信息,1999,14(8)：13-15.
[26]孙海英,刘树文.谷维素和盐酸小檗碱合用治疗室性心律失常91例[J].陕西医学杂志,2007,36(7)：925-926.
[27]李辉.盐酸小檗碱在心血管疾病中的应用[J].临床军医杂志,2005,33(4)：815-816.
[28]杜见益.黄连素治疗心律失常108例的疗效观察[J].海南医学,2006：17(7)：86-71.
[29]Wang YX, Zheng YM, Zhou XB. Inhibitory effects of berberine on ATP. sensitive K+ channels in cardiac myocytes[J].Eur J Pharmacol,1996,316(3):307-315.
[30]黄伟民等.黄连素治疗心律失常的基础电生理学研究[J].心电学杂志,1985,12(4)：2.
[31]黄伟民等.黄连素延长腺鼠心室乳头肌动作电位时程的机理研究[J].心电学杂志,1987,21(6)：49.
[32]方诂超等.小檗碱的抗心室纤颤作用[J].中国药理学报,1986,7(4)：321.
[33]孙晓东,李金鸣,田丽君等.小檗碱对豚鼠心室乳头状肌慢内向离子电流的作用[J].中国药理学报,1989,10(2)：130-134.
[34]黄伟民等.黄连素对小鼠心肌内总钙维度的影响[J].中国药学杂志,1990,25(1)：3.
[35]司晓晨.盐酸小檗碱片对钙离子通道的拮抗作用[J].南京中医药大学学报,1996,12(6)：20-22.
[36]王建文,张文军.盐酸小檗碱的几种新用途[J].中国医学杂志,2004,2(8)：507-508.
[37]Wang YX, Yao XY, Tan YH. Effects of berberine on delayed after depolarizations in ventricular muscles in vitro and in vivo[J].J Cardiovasc Pharmacol,1994,23(36):7216-7221.
[38]Huang WM, Yan H, Lin JM, et al. Beneficial effects of berberine on hemodynamics during acute ischemic left ventricular failure in dogs[J].Chin Med J,1992,105(12):1014-1019.
[39]杨立新.黄连素治疗高血压病53例疗效观察[J].临床荟萃,1990,5(10)：454.
[40]林斌,陈维圣.黄连素一个月疗法治疗高血压伴室性早搏的临床观察[J].福建医药杂志,1996,18(1)：98-99.
[41]郝文.黄连素在内科疾病中的应用[J].实用中医内科杂志,1997,11(2)：20.
[42]钟树林,周永生,陈海明等.黄连素治疗老年高血压病96例临床观察[J].中国老年学杂志,1997,17(6)：349-350.
[43]韩振祥,黄金秀,张志深等.倍他乐克加黄连素治疗老年高血压病观察[J].医学研究通讯,1999,28(4)：43.
[44]张学芳,徐祗云,李玉平.黄连素的临床新用途[J].职业与健康,2000,16(6)：94-95.
[45]王辉武.中药临床新用[M].北京：人民卫生出版社,2001.547.
[46]魏银福,刘宏义.黄连素治疗高血压病38例疗效观察[J].内蒙古医学杂志,2000,32(3)： 192-193.
[47]张思坦,潘俊亭.黄连素治疗高血压病82例临床观察[J].包头医学院学报,1996,12(1)：46-47.
[48]王文雅,陈克敏,关永源等.盐酸小檗碱对毒草碱型受体的作用[J].药学学报,1999,34(4)：260-263.
[49]Kang DG, Sohn EJ, Kwon EK, etal. Effects of berberine on angiotensin-converting enzyme and NO/cGMP system in vessels[J].Vasc Pharmacol,2002,39(6):281-286.
[50]Ko WH, Yao XQ, Lau CW, etal. Vasorelaxant and anti-proliferative effect of berberine[J].Eur J Pharmacol,2000,399(2):187-196.
[51]Chi CW, Chang YF, Chao TW, etal. Flowcometric analysis of the effect of berberine on the expression of glucocorticoid receptors in human hepatoma HepG2 ceils[J].Life Sci,1994,54(64):2099-2107.
[52]何国厚,刘勇,艾志兵等.小檗碱对兔颈动脉粥样硬化形成的干预作用[J].神经损伤与功能重建,2006,1(1)：42-44.
[53]左彦方,郭毅,姜昕等.小檗碱对兔动脉粥样硬化及其血脂的影响[J].中国脑血管病杂志,2006,3(5)：204-207.
[54]何国厚,艾志兵,刘勇等.小檗碱对兔颈动脉粥样硬化中内膜增生和吞噬细胞趋化作用的影响[J].中风与神经疾病杂志,2006,23(1)：94-96.
[55]周岚,何国厚,李承晏等.小檗碱对颈动脉粥样硬化家兔血管紧张素的影响[J].卒中与神经疾病,2006,13(4)：212-214.
[56]Eden ER, Patel DD, Sun XM, etal. Restoration of LDL Receptor function in cells from patients with autosom al recessive hypercholesterolemia by retroviral expression of ARH1[J].J Cin Invest,2002,110(11):1695-1702.
[57]Lee S, Lim HJ, Park JH, et al. Berberine-induced LDLR up-regulation involves JNK pathway[J].Biochem Biophys Res Commun,2007,362(4):853-857.
[58]Clabaut A, Deplace S, Chauveau C, etal. Human osteob lasts derived from m esenchym stem cells express adipogenic marker upon coculture with bone marrow adipocyte[J]. Differen tiation,2010,80(1):40-45.
[59]Xing LJ, Zhang L, Lin T, et al. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease(NAFLD) rat liver[J].Eur J Pharmacol, 2011,668(3):467-471.
[60]陈其明,谢明智.黄连及小檗碱降血糖作用的研究[J].药学学报,1986,21(6)：401-4031.
[61]李萍.小檗碱对心血管系统的药理作用[J].中国药学通报,2001,7(5)：324.
[62]Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus[J]. Metabolism,2008,57(13):712.
[63]陈其明,谢明智.黄连及小檗碱降血糖作用的研究[J].药学报,1986,21(16)：401-406.
[64]宋菊敏,毛良,施建玲等.黄连素对非胰岛素依赖型糖尿病大鼠的抗氧化作用[J].中草药,1992,23(11)：590-591.
[65]金丹.黄连解毒汤及黄连素对2型糖尿病大鼠靶组织中磷脂酰肌醇-3激酶mRNA和蛋白表达的影响[D].华中科技大学硕士学位论文,2006：9.
[66]闫秀敏,黎明,邢雪林.浅谈黄连素的药理与临床应用[J].中国医药卫生,2005,6(3)：62.
[67]唐玲光.黄连素巧治糖尿病[J].医药与保健,2005,13(6)：40.
[68]李素迎,姚运纬,伍忍.盐酸小檗碱对链脲霉素致大鼠离体胰岛B细胞损伤的影响[J].中国现代医学杂志,2002,12(18)：6-8.
[69]Yu C, Zhang H, Pan JF, etal. Determination and preliminary studies of metabolism of berberine in human urine after oral administration[J].Chin J Clin Pharmacol(中国临床药理学杂志),2000,16(1)：36-39.
[70]Pan JF, Yu C, Zhu DY, etal.Identification of three sulfate conjugated metabolites of berberine chloride in healthy volunteer's urine after oral administration[J]. Acta Pharmacol Sin(中国药理学报),2002,23(1)：77-82.
[71]宋菊敏,毛良,李有良.黄连对2型糖尿病的抗氧化作用[J].中草药,1992,23(11)：540.
[72]吕霞,王晶,蒋文强等.黄连的研究进展.山东医药工业[J],2003,22(6)：33-35.
[73]Liu WH, Hei ZQ, Nie H, et al. Berberine ameliorates renal injury in streptozotocin -induced diabetic rats by suppression of both oxidative stress and aldose reductase[J].Chin Med J(Engl), 2008,121(36):706.
[74]Zhou LB, Wang X, Shao L, et al. Berberine Acutely Inhibits Insulin Secretion fromβ-Cells through 3,5-Cyclic Adenosine 5-Monophosphate Signaling Pathway[J]. Endocrinology,2008, 149(9):4510.
[75]Tang LQ, Wei W, Chen LM, et al. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats[J].J Ethnopharmacol,2006,108:109.
[76]李应霞,成小蔓,何海霞.黄连小檗碱对大鼠糖尿病模型中血糖的影响[J].医学研究杂志,2007,26(11)：70.
[77]Fu D, O Neill RA. Monosaccharide composition analysis of oligosaccharides and glycoproteins by high 2 performance liquid chromatography[J].Anal Biochem,1995,227(2):337-384.
[78]Xiong MQ, Zhu ZZ.The study of diabetis treatment and insulin resistance improvement by Chinese medicine[J].Chin Tradit Med New Drugs Clin Pharmacol (中药新药与临床药理), 1994,5(4):47-50.
[79]Gao CR, Zhang JQ, Hung QL. Experimental study on berberin raised insuliu sensitivity in insul inresistance rat models[J].Chin J Integrated Tradit West Med (中国中西医结合杂志), 1997,17(3):162-164.
[80]Lu SS, Yu YL, Zhu Haojie, etal. Berberine promotes glucagon-like peptide-1(7-36) amide secretion in streptozotocin-induced diabetic rats [J]. Society for Endocrinology,2008,1 (2):120-122.
[81]Cheng Z, Pang T, Gu M, etal. Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK[J].Biochim Biophys Acta,2006,14(13):678-682.
[82]Woo Sik Kim, Yun Sok Lee, Seung Hun Cha, etal. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. Am J Physiol Endocrinol Metab[J].2009,36(24):812.
[83]Kong WJ, Zhang H, Song DQ, etal. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression[J].Metabolism,2009,9(58): 109.
[84]LIN CC, LIN SY, CHUNG JG, etal. Down-regulation of cyclin B1 and up-regulation of Weel by berberine promotes entry of leukemia cells in to the G2/M-phase of the cell cycle[J].Anticancer Res,2006,10(26):1097-1104.
[85]魏敬,吴锦丹,蒋建东等.盐酸小檗碱治疗2型糖尿病合并脂肪肝的临床研究[J].中西医结合肝病杂志,2004,14(6)：334.
[86]Zhang Y, Li X, Zou D,etal. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine[J].J Clin Endocrinol Metab,2008,93(7):2559.
[87]Yin J, Xing H, Ye J. Efficacy of berberine in patient s with type 2 diabetes mellitus[J]. Metabolism,2008,57(5):712.
[88]Zhou JY, Zhou SW, Zhang KB, et al.Chronic effects of berberine on blood,liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats[J]. Biol Pharm Bull, 2008,31(6):1169.
[89]欧阳礼枝,陆付耳,刘文军等小檗碱对胰岛素抵抗大鼠肝脏葡萄糖激酶及其调节蛋白的影响[J].世界华人消化杂志,2007,15(8)：885.
[90]王增四,陆付耳,陈广等.小檗碱对NIT-1细胞胰岛素分泌和葡萄糖激酶活性的影响[J].药学学报,2007,42(10)：1045.
[91]Kong W, Wei J, Abidi P, etal. Berberine is a novel cholesterol lowering drug working through a unique mechanism distinct from statins[J]. Nat Med,2004,10(12):1344.
[92]Brusq JM, Ance llin N, Grondin P, etal.Inhibition of lipid synthesis through activation of AMP kinase an additional mechanism for the hypolipidemic effects of berberine[J].J Lipid Res,2006,47(6):1281-1288.
[93]Kong W, Wei J, Abidi P, etal. Berberine is a novel cholesterol21owering drug working through a unique mechanism distinct fromstatins[J]. Nat Med,2004,10(12):1344.
[94]Huang C, Zhang Y, Gong Z, etal.Berberine inhibits 3T32L1 adipocyte differentiation through the PPAR gamma pathway[J].Biochem Biophys Res Commun,2006,348(2):571.
[95]Cemakova M, Kostalova D. Antimicrobial activity of berberine-a constituent Of Mahonia aquifolium[J].Folia Mierobiol,2002,47(4):375-378.
[96]马连珍,王爱玲,刘和善.黄连的临床应用[J].中国民间疗法,2003,11(8)：44-45.
[97]周祖玉,徐建国,蓝庭剑.黄连素对灌流心脏发生心衰的保护作用[J].华西医科大学学报,2001,32(3)：417-418.
[98]智光,黄大显,杨兴生.黄连素治疗心功能衰竭的实验和临床观察[J].中华内科杂志,1991,30(9)：581-582.
[99]康巧真,叶菲,杨顺裕.黄连素治疗充血性心力衰竭17例疗效观察[J].中国自然医学杂志,2002,4(2)：83-84.
[100]董德利,孙建平,罗大力等.小檗碱对豚鼠心室肌细胞胞浆内游离钙离子浓度的影[J].中国药理学与毒理学杂志,2000,14(2)：128-130.
[101]Hui KK, Yu JL, Chan WF. etal. Interaction of berberine with human platelet alpha 2 adrenoceptors[J].Life Scicene,1991,49(18):315-324.
[102]汪永孝,姚秀娟,谭月华.小檗碱对豚鼠离体心肌生理特性的影响[J].中国药理学报,1987,8(3)：220-223.
[103]唐青云,李国海,李久玲等.静滴盐酸黄连素对心血管机能的影响[J].医药工业,1985,16(3)：130-132.
[104]李新天,王幼林.小檗碱对培养大鼠心肌细胞胞内游离Ca的作用[J].药学学报,1997,32(10)：721-725.
[105]宋云可,刘红旗,李世东.小檗碱对心血管系统的作用及临床应用[J].山东医药工业,1997,16(5)：28-29.
[106]关中宪.黄连素治疗心力衰竭28例[J].临床荟萃,1993,8(17)：859.
[107]Hong Y, Hui SS, Chan BT, etal. Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy[J].Life Sci,2003,72(22):2499-2507.
[108]HONG Y, HUI S C, CHAN T Y, etal. Effect of berberine on regression of pressure overload induced cardiac hypertrophy in rats[J].Am J of Chinese M, Micine,2002,30(4):588-599.
[109]洪缨,解欣然,谢俊大等.小檗碱对压力超负荷致心肌肥厚模型大鼠心脏结构的影响[J].北京中医药大学学报,2006,29(7)：465-467.
[110]洪缨,王晶,赵海苹等小檗碱对2肾1夹致心肌肥厚大鼠心室重构的影响[J].北京中医药大学学报,2005,28(6)：28-31.
[111]Ji ES, Yue H, Wu YM, etal. Effects of phytoestrogen genistein on myocardial ischemia /reperfusion injury and apoptosis in rabbits[J].Acta Pharmacol sin,2004,25(3):306-312.
[112]熊利华,苏艳玲,华平等.不停跳心内直视手术的临床研究[J].中山大学学报(医学科学版),2004,25(1)：221-223.
[113]HON6 Y, HM ISC, CHA NTY, etal.Effect of berberine on regres sion0f Press LI recover 10 adind Ucedcardiac hypertrophy in rats. Am J of Chinese[J], Micine,2002,30(4):588-599.
[114]Hong Y, Hui SS, Chan B T, etal. Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy[J]. Life Scicene,2003,72(22):2499-2507.
[115]Huang M, Yan H, Lin JM, etal. Beneficial effects of berberine on hemodynamics during acute ischemic left ventricular failure in dogs[J].Chin Med J,1992,105(12):1014-1019.
[116]Wang CM, Li J, Lv X etal. Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin[J].Eur J Pharmacol,2009,620(1):131-137.
[117]Wang YQ, Huang Lam KS, etal. Berberine prevents hypergly-cemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase[J].Cardiovasc Res,2009,82(3):484-492.
[118]Kang DG, Sohn EJ, Kwon EK, etal. Effects of berberine on angiotensin-converting enzyme and NO/cGM P system in vessels[J].Vase Pharrnacol,2002,39(6):281-286.
[119]Correch6 ER, Andujar SA, Kurdelas RR, etal. Antioxidant and cytotoxic activities of canadine:biological effects and structural aspects[J].Bioorg Med Chem,2008,16(7):3641-3651.
[120]Thimpurasundari CJ, Pedmini R, Devaraj SN. Effect of berberine Oil the antioxidant, uhmstruetural modifications and protein bound carbohydrates in azoxymethane-induced Colon cancer in rats[J].Chem Biol Interact,2009,177(3):190-195.
[121]Choi DS, Kim SJ, Jung MY. Inhibitory activity of berbefine on DNA strand cleavage induced by hydrogen peroxide and cytochromec[J].Biosei-Biotechnol-Bioehem,2001,65(2):452-455.
[122]刘星.蜂王浆对实验性2型糖尿病大鼠心肌的保护作用[J].牡丹江医学院报,2003,24(5)：1-3.
[123]Shirwaikar A, Shirwaikar A, Pmjendmn K, etal.In vitro antiox-idant studies on the benzyl tetra isoquinoline alkaloid berbefine[J].Biol Pharm Bull,2006,29(9):1906-1910.
[124]Weaver ME. A quantitative study of the anatomy and distribution of coronary arteries in comparison with other animals and man[J].Cardiovasc Res,1986,20(12):907.
[125]刘国辉,刘志跃.实验性心肌梗死动物模型复制方法研究进展[J].实验动物科学与管理,2005,22(4)：362.
[126]Berg RA, Sanders AB, Kern KB, etal. Adverse hemodynamic effects of interrupting chest compressions for rescue breat hing during cardiopulmonary resuscitation for ventricular cardie arrest[J].Circulation,2001,104(20):2465.
[127]Odenstedt J, Mansson C, Jansson SO, etal. Endocardial electromechanical mapping in a porcine acute infarct and reperfusion model evaluating the extent of myocardial ischemia[J].J Invasive Cardiol,2003,15(9):497.
[128]Zhao ZQ, Vinten-Johansen J. Postconditioning:Reduction of reperfusion-induced injury[J]. Cardiovasc Res,2006,70(2):200-211.
[129]Crisostomo PR, Wairiuko GM, Wang M, etal. Preconditioning versus postconditioning: mechanisms and therapeutic potentials[J].Am Coll Surg,2006,202(5):797-812.
[130]Skyschally A, Schulz R, Heusch G. Pathophysiology of myocardial infarction:protection by ischemic pre- and postconditioning[J].Herz,2008,33(2):88-100.
[131]卢新政,王连生,黄峻等.冠状动脉堵闭法建立猪心肌梗死模型[J].中国动脉硬化杂志,2004,12(2)：218.
[132]徐淑云.药理实验方法学(第3版)[M].北京：人民卫生出版社,2002：921.
[133]Reek S, Bicknell JL, Walcott GP, etal. Induciblity of sustained ventricular tachycardia in a closed-chest ovine model of myocardial infarction[J].Pacing Clin Electrophysiol,1999,22(4): 605-614.
[134]Sasaki H, Shimizu M, Ogawa K, etal. Brief ischemia-reperfusion performed after prolonged ischemia (ischemic postconditioning) can terminate reperfusion arrhythmias with no reduction of cardiac function in rats[J].Int Heart J,2007,48(2):205-213.
[135]Vinten-Johansen J. Postconditioning:a mechanical maneuver that triggers biological and molecular cardioprotective responses to reperfusion[J].Heart Fail Rev,2007,12(3):235--244.
[136]Hausenloy DJ, Yellon DM. Survival kinases in ischemic preconditioning and postconditioning[J]. Cardiovasc Res,2006,70(2):240-253.
[137]金惠铭,王建枝.病理生理学(第6版)[M].北京：人民卫生出版社,2006：214.
[138]金惠铭,王建枝.病理生理学(第7版)[M].北京：人民卫生出版社,2006：207.
[139]Huang Z, Wang L, Meng S, etal. Berberine reduces both MMP-9 and EMMPRN expression through prevention of P38 pathway activation in PMA-induced macrophages[J].Int J Cardiol,2009,36(12):224-225.
[140]Kim S, Choi JH, Kim JB, etal. Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer celIs[J].Molecules,2008,13(15):2978-2985.
[141]Lin JF, Yang JS, Wu CC, etal. Berberine induced down-regulation of matrix metalloproteinase-1,-2 and -9 in human gastric cancer cells(SNU-5) in vitro[J].In Vivo,2008, 22(18):223-230.
[1]潘清平,黄连[M].北京：中国中医药出版社,2001,3-4.
[2]江苏新医学院编.中药大辞典[M].上海：上海科学技术出版社,1996：2024-2025.
[3]杨勇,叶小利,李学刚.4种黄连生物碱的抑菌作用[J].时珍国医国药,2007,12,18(12)：3013-3014.
[4]Yang Y, Ye X L, Li X G, et al. Synthesis and antimicrobial activity of 8-alkyl berberine derivatives with a long aliphatic chain[J].Planta Med,2007,73:602-604.
[5]孟甄,金建玲,刘玉庆等.细菌耐药性的诱导与消除[J].中国药理学通报,2003,19(9)：1047-1051.
[6]Tae S, Kim H, Bok Y, etal. Induction of interleuk in 212 production in mouse marcophage by berberine, a benzodioxo loquino lizine alkaloid, deviates CD4+ T cells from a Th2 to a Thl respones[J].Immunology,2003,109:407-414.
[7]HUANG CG,CHU ZL. Effect of berberine on arachidonic acid metabolism in rabbit plate lets and endothelial cells[J].Thromb Res,2002,106(4-5):223-227.
[8]Russel Ross. A therosclerosis an inflammation disease[J].The New England Journal of Medicine,1999,340(2):115-126.
[9]方放治,戴得哉,王自正等.氯苄四氢小檗碱对抗H202引起无血清培养的血管内皮细胞凋亡及坏死[J].中国临床药理学杂志,2002,7(3)：200-204.
[10]Kang DG, Sohn EJ, Kwon EK, et al. Effect of berberine on abgio tensin2converting enzyme and NOocGM P system in vessels[J].Pharmaco,2002,39 (1):281.
[11]Huang CG, Chu Zhong L, Wei Shang J. Effect of berberine on arachidonic acid metabolism in rabbit platelets and endothelial cell[J].Thrombosis Rearch,2002,106:223-227.
[12]席刚明,何国厚,黄朝芬等.小檗碱对脑梗死患者血浆ICM21和E2-Selectin的影响[J].中风与神经疾病杂志,2003,20(6)：273.
[13]Ko WH, Wao XQ. Vaso relaxant and anti-proliferative effect of berberine [J]. European Journal of Pharmaco logy,2000,39 (9):187-196.
[14]Cui HS, Matsumoto K, Murakami Y, etal. Berberine exerts neuroprotective actions against in vitro ischemia-induced neuronal cell damage in organotypic hippocampal slice cultures:involvement of B-cell lymphoma 2 phosphorylation suppression[J].Biol Pharm Bull,2009,32(1):79-85.
[15]陈施艳,林红,吴秀丽等.小檗碱对大鼠脑缺血后MCP-1表达的影响[J].卒中与神经疾病,2008,15(4)：323-326.
[16]Wang F, Zhao G, Cheng L, etal. Effects of berberine on potassium currents in acutely isolated CA1 pyramidal neurons of rat hippocampus. Brain Res[J].2004,999(1):91-97.
[17]于秀辰,李靖,王世东.黄连素在糖尿病中的治疗作用.中国基础医学杂志,2002,8(10)：46-48.
[18]于秀辰,李靖,赵进喜.黄连素治疗2型糖尿病30例临床观察.中国临床医生,2003,31(5)：48.
[19]刘长山,王秀军,柳林等.黄连素对醛糖还原酶活性的抑制及其防治糖尿病神经病变的临 床意义.中国中药杂志,2002,27(12)：950-952.
[20]高从容,张家庆,黄庆玲.黄连素增加胰岛素抵抗大鼠模型胰岛素敏感性的实验研究.中国中西医杂志,1997,17(3)：162-164.
[21]陈莉,张玉.黄连素合六味地黄丸治疗2型糖尿病123例[J].国医论坛,2002,17(2)：37.
[22]姚冬春,王雪莲,扬志.黄连素的临床新用途[J].牡丹江医学院学报,2001,22(1)：70.
[23]徐蓉,徐孝麟.黄连素在非感染疾病中的临床应用[J].实用医院临床杂志,2005,2(4)：87.
[24]HUANG CG,CHU ZL. Effect of berberine on arachidonic acid metabolism in rabbit plate lets and endothelial cells[J].Thromb Res,2002,106(4-5):223-227.
[25]HAO Y, QIU QY, Wang WJ, etal. Effects of berberine on lymphocyte-endothelium adhesion and adhesion molecule expression[J].Chin J Immuno,1999,15(11):523-525.
[26]Jing Wang, Yanjun Zhang, Shuai Du, etal. Protective effects of berberine against amyloid beta-induced toxicity in cultured rat corticalneurons[J].Neural Regeneration Research,2011,6(3):183-187.
[27]李彩莲,王芳,刘超等小檗碱对Aβ25-35诱导大鼠PC12细胞损伤的保护作用[J].中国科技论文在线,2006,1(1)：269-274.
[28]Guang Y, Li Y, Tian Q, etal. Berberine Attenuates Calyculin AInduced Cytotoxicity and Tau Hyperphosphorylation in HEK293 Cells[J].J Alzheimers Dis,2011, 24(2):1-2.
[29]Asai M, Iwata N, Yoshikawa A, etal. Maruyama K. Berberine alters the processing of Alzheimers amyloid precursor protein to decrease Abeta secretion [J].Biochem Biophys Res Commun,2007,352(2):498-502.
[30]Domitrovi R, Jakovac H, Blagojevi G. Hepatoprotective activity of berberine is mediated by inhibition of TNF-a, COX-2, and i-NOS expression in CCl(4)-intoxicated mice[J]. Toxicology, 2011,280(1-2):33-43.
[31]Cui HS, Matsumoto K, Murakami Y, etal. Berberine exerts neuroprotective actions against in vitro ischemia-induced neuronal cell damage in organotypic hippocampal slice cultures:involvement of B-cell lymphoma 2 phosphorylation suppression[J].Biol Pharm Bull,2009,32(1):79-85.
[32]Sabir M. Indian J Med Res,1977(65):305.
[33]孙强,朱冰芝,陈亚娟.黄连灌肠治疗慢性溃疡性结肠炎173例[J].现代中西医结合杂志,2003,12(10)：1024.
[34]Subbaramaiah K, Dannenkerg AJ.Cyclooxygenase2:a molecular target for cancer prevention and treatment[J].Trends in pharmacological sciences,2003,24(2):96.